VR Close Other for Pain Threshold
Phase-Based Progress Estimates
Effectiveness
Safety
Pain Threshold
VR Close Other - BehavioralEligibility
18+
All Sexes
What conditions do you have?
Select
Eligibility
18+
All Sexes
What conditions do you have?
Select
Study Summary
This trial will study whether social interaction with close others or strangers can help reduce pain in healthy volunteers.
Treatment Effectiveness
Study Objectives
1 Primary · 3 Secondary · Reporting Duration: Experience and subsequent survey time 5-15 minutes
15 minutes between samples
Cortisol levels
Experience and subsequent survey time 5-15 minutes
Self-reported environmental presence
Self-reported social presence
The beginning and end of each trial < 90 seconds
Pain threshold in degrees tolerated at end of trial
Trial Safety
Trial Design
4 Treatment Groups
Time 2
1 of 4
Time 1
1 of 4
Time 3
1 of 4
Time 4
1 of 4
Active Control
Experimental Treatment
75 Total Participants · 4 Treatment Groups
Primary Treatment: VR Close Other · No Placebo Group · N/A
Time 4Experimental Group · 4 Interventions: VR Close Other, VR Alone, VR Stranger, Video Close Other · Intervention Types: Behavioral, Behavioral, Behavioral, Behavioral
Time 2ActiveComparator Group · 4 Interventions: VR Close Other, VR Alone, VR Stranger, Video Close Other · Intervention Types: Behavioral, Behavioral, Behavioral, Behavioral
Time 1ActiveComparator Group · 4 Interventions: VR Close Other, VR Alone, VR Stranger, Video Close Other · Intervention Types: Behavioral, Behavioral, Behavioral, Behavioral
Time 3ActiveComparator Group · 4 Interventions: VR Close Other, VR Alone, VR Stranger, Video Close Other · Intervention Types: Behavioral, Behavioral, Behavioral, Behavioral
Trial Logistics
Trial Timeline
Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: experience and subsequent survey time 5-15 minutes
Who is running the clinical trial?
Cornell UniversityLead Sponsor
148 Previous Clinical Trials
100,684 Total Patients Enrolled
Eligibility Criteria
Age 18+ · All Participants · 1 Total Inclusion Criteria
Mark “yes” if the following statements are true for you:About The Reviewer
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.
Who else is applying?
What state do they live in?
| New York | 100.0% |
How old are they?
| 18 - 65 | 100.0% |
What site did they apply to?
| Cornell Virtual Embodiment Lab | 100.0% |
What portion of applicants met pre-screening criteria?
| Met criteria | 100.0% |
How responsive is this trial?
Typically responds via
| 100.0% | |
Popular Clinical Trials
Top Clinical Trials in Cities
Relevant Clinical Trials
Unbiased Results
We believe in providing patients with all the options.Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.Back to top
Conditions
Cancer Related
Treatments